The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C6 position

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

卷:22

Article

Choi, Sun Ea¹  Pflum, Mary Kay H.¹ 

[1] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA

关键词: Histone deacetylase;    HDAC inhibitor;    Isoform selectivity;    Vorinostat;   

DOI  :  10.1016/j.bmcl.2012.09.093

来源: Elsevier

【 摘 要 】

Suberoylanilide hydroxamic acid (SAHA, Vorinostat), the first FDA-approved histone deacetylase (HDAC) inhibitor drug, was modified at the C6 position to study the structural requirements for high potency and selectivity. Substituents on the C6 position only modestly influenced inhibitor potency, with poorer activity observed as substituent size increased. Interestingly, C6 substituents also modestly influenced selectivity compared to the parent compound, SAHA. This systematic study documenting the influence of substituents on the SAHA linker region will aid development of anti-cancer drugs targeting HDAC proteins. (C) 2012 Elsevier Ltd. All rights reserved.

【 授权许可】

Free